Allurion Technologies, Inc. Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect
Allurion Technologies, Inc. (ALUR) reported Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect of -$3.75 million for the 12-month period ending 2023-12-31, per its 10-K/A filed 2025-08-28.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDebtInstrumentValuationTechniquesChangeInTechniqueQuantificationOfEffect · last filed 2025-08-28
- Allurion Technologies, Inc. fair value, debt instrument, valuation techniques, change in technique, quantification of effect for the quarter ending 2023-12-31 was $0.00.
- Allurion Technologies, Inc. fair value, debt instrument, valuation techniques, change in technique, quantification of effect for the quarter ending 2023-09-30 was -$6.01M.
- Allurion Technologies, Inc. fair value, debt instrument, valuation techniques, change in technique, quantification of effect for fiscal 2023 was -$3.75M.
| Period end | Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect 3 month | Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect 6 month | Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect 9 month | Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | -$6.01M derived: sum of 2 quarters · filed 2025-08-28 | -$3.75M 10-K/A · filed 2025-08-28 | |
| 2023-09-30 | -$6.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$3.75M 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $2.26M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |